Parminder Kaur1, Aruna Aggarwal2, Madhu Nagpal3, Loveena Oberoi2, Swati Sharma3. 1. Department of Microbiology, Sri Guru Ram Das Institute of Medical Sciences and Research, Amritsar, India ; H. No. 1658, Phase 7, Mohali, 160062 Punjab India. 2. Department of Microbiology, Sri Guru Ram Das Institute of Medical Sciences and Research, Amritsar, India. 3. Department of Obstetrics and Gynaecology, Sri Guru Ram Das Institute of Medical Sciences and Research, Amritsar, India.
Abstract
OBJECTIVE: Cervical cancer is the commonest cancer among Indian women. High-risk human papilloma virus (HPV) detection holds the potential to be used as a tool to identify women, at risk of subsequent development of cervical cancer. There is a pressing need to identify prevalence of asymptomatic cervical HPV infection in local population. In our study, we explored the prevalence of HPV genotypes and their distribution in women with cervical lesions. METHODS: Scrape specimens were obtained from 100 women (study group) with cervical abnormalities. HPV was detected with amplicor HPV tests, and the individual genotypes in these specimens were identified by Hybribio Genoarray test kit. Fifty specimens were also collected from females with healthy cervix (control group). The present study also aimed to determine the status of HPV prevalence and its association with different sociodemographic factors. RESULTS: Out of the total number of 100 samples, 10 (10 %) women tested positive for HPV DNA. Among them, HPV 18 was observed in 6, HPV 16 in 2, HPV 52 and HPV 39 in one each. Fifty specimens collected from patients with healthy cervix were not infected with any of the HPV genotype. CONCLUSIONS: Our study generates data of HPV prevalence in patients with cervical lesions visiting tertiary care institute. The data generated will be useful for laying guidelines for mass screening of HPV detection, treatment, and prophylaxis.
OBJECTIVE:Cervical cancer is the commonest cancer among Indian women. High-risk human papilloma virus (HPV) detection holds the potential to be used as a tool to identify women, at risk of subsequent development of cervical cancer. There is a pressing need to identify prevalence of asymptomatic cervical HPV infection in local population. In our study, we explored the prevalence of HPV genotypes and their distribution in women with cervical lesions. METHODS: Scrape specimens were obtained from 100 women (study group) with cervical abnormalities. HPV was detected with amplicor HPV tests, and the individual genotypes in these specimens were identified by Hybribio Genoarray test kit. Fifty specimens were also collected from females with healthy cervix (control group). The present study also aimed to determine the status of HPV prevalence and its association with different sociodemographic factors. RESULTS: Out of the total number of 100 samples, 10 (10 %) women tested positive for HPV DNA. Among them, HPV 18 was observed in 6, HPV 16 in 2, HPV 52 and HPV 39 in one each. Fifty specimens collected from patients with healthy cervix were not infected with any of the HPV genotype. CONCLUSIONS: Our study generates data of HPV prevalence in patients with cervical lesions visiting tertiary care institute. The data generated will be useful for laying guidelines for mass screening of HPV detection, treatment, and prophylaxis.
Entities:
Keywords:
Cervical cancer; Genotyping; Human papilloma virus
Authors: A Peedicayil; P Abraham; N Sathish; S John; K Shah; G Sridharan; P Gravitt Journal: Int J Gynecol Cancer Date: 2006 Jul-Aug Impact factor: 3.437
Authors: C Duttagupta; S Sengupta; M Roy; D Sengupta; P Bhattacharya; P Laikangbam; S Roy; S Ghosh; R Das Journal: Int J Gynecol Cancer Date: 2004 Mar-Apr Impact factor: 3.437
Authors: Silvia Franceschi; Thangarajan Rajkumar; Salvatore Vaccarella; Vendhan Gajalakshmi; Ajit Sharmila; Peter J F Snijders; Nubia Muñoz; Chris J L M Meijer; Rolando Herrero Journal: Int J Cancer Date: 2003-10-20 Impact factor: 7.396
Authors: Mark E Sherman; Attila T Lorincz; David R Scott; Sholom Wacholder; Philip E Castle; Andrew G Glass; Iwona Mielzynska-Lohnas; Brenda B Rush; Mark Schiffman Journal: J Natl Cancer Inst Date: 2003-01-01 Impact factor: 13.506